Frederic Pont
Overview
Explore the profile of Frederic Pont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
979
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Lahoum A, Sabaou N, Bijani C, Bouras N, Pont F, Snini S, et al.
Saudi Pharm J
. 2019 Jan;
27(1):56-65.
PMID: 30662307
The actinobacterium strain ABH26 closely related to , isolated from an Algerian Saharan soil sample, exhibited highly antagonist activity against Gram-positive bacteria, yeasts and filamentous fungi. Its ability to produce...
22.
Franchini D, Lanvin O, Tosolini M, Patras De Campaigno E, Cammas A, Pericart S, et al.
Cell Rep
. 2019 Jan;
26(1):94-107.e7.
PMID: 30605689
Despite the clinical success of blocking inhibitory immune checkpoint receptors such as programmed cell death-1 (PD-1) in cancer, the mechanisms controlling the expression of these receptors have not been fully...
23.
Le Roy A, Prebet T, Castellano R, Goubard A, Riccardi F, Fauriat C, et al.
Front Immunol
. 2018 May;
9:977.
PMID: 29780393
Immunomodulatory drugs (IMiDs) are anticancer drugs with immunomodulatory, anti-angiogenesis, anti-proliferative, and pro-apoptotic properties. IMiDs are currently used for the treatment of multiple myeloma, myelodysplastic syndrome, and B-cell lymphoma; however, little...
24.
Driche E, Sabaou N, Bijani C, Zitouni A, Pont F, Mathieu F, et al.
World J Microbiol Biotechnol
. 2017 May;
33(6):105.
PMID: 28466299
A novel actinobacterium strain, named AT37, showed a strong activity against some multidrug-resistant Staphylococcus aureus, including methicillin-resistant S. aureus MRSA ATCC 43300, other clinical isolates of MRSA and vancomycin resistant...
25.
Tosolini M, Pont F, Poupot M, Vergez F, Nicolau-Travers M, Vermijlen D, et al.
Oncoimmunology
. 2017 Apr;
6(3):e1284723.
PMID: 28405516
Most human blood γδ cells are cytolytic TCRVγ9Vδ2 lymphocytes with antitumor activity. They are currently investigated in several clinical trials of cancer immunotherapy but so far, their tumor infiltration has...
26.
Tosolini M, Algans C, Pont F, Ycart B, Fournie J
Oncoimmunology
. 2016 Sep;
5(7):e1188246.
PMID: 27622044
Non-Hodgkin B-cell lymphoma (B-NHL) are aggressive lymphoid malignancies that develop in patients due to oncogenic activation, chemo-resistance, and immune evasion. Tumor biopsies show that B-NHL frequently uses several immune escape...
27.
Sing D, Fortney J, Nikolov N, Wakeford H, Kataria T, Evans T, et al.
Nature
. 2015 Dec;
529(7584):59-62.
PMID: 26675732
Thousands of transiting exoplanets have been discovered, but spectral analysis of their atmospheres has so far been dominated by a small number of exoplanets and data spanning relatively narrow wavelength...
28.
Ligat L, Saint-Laurent N, El-Mrani A, Gigoux V, Al Saati T, Tomasini R, et al.
Br J Cancer
. 2015 Oct;
113(11):1590-8.
PMID: 26512875
Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies with a mortality that is almost identical to incidence. Because early detected PDAC is potentially curable, blood-based biomarkers...
29.
Tosolini M, Pont F, Verhoeyen E, Fournie J
Eur J Immunol
. 2015 Oct;
45(12):3313-23.
PMID: 26460927
Cyclic dinucleotides, a class of microbial messengers, have been recently identified in bacteria, but their activity in humans remains largely unknown. Here, we have studied the function of cyclic dinucleotides...
30.
Buscail L, Bournet B, Vernejoul F, Cambois G, Lulka H, Hanoun N, et al.
Mol Ther
. 2015 Jan;
23(4):779-89.
PMID: 25586689
This phase 1 trial was aimed to determine the safety, pharmacokinetics, and preliminary clinical activity of CYL-02, a nonviral gene therapy product that sensitizes pancreatic cancer cells to chemotherapy. CYL-02...